Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion

Mitochondrial glucose metabolism is essential for stimulated insulin release from pancreatic β-cells. Whether mitofusin gene expression, and hence, mitochondrial network integrity, is important for glucose or incretin signaling has not previously been explored. Here, we generated mice with β-cell-se...

Full description

Bibliographic Details
Main Authors: Akalestou, E. (Author), Ali, Y. (Author), Alsabeeh, N. (Author), Chabosseau, P. (Author), Cruciani-Guglielmacci, C. (Author), Georgiadou, E. (Author), Gu, G. (Author), Ibberson, M. (Author), Jones, B. (Author), Leclerc, I. (Author), Legido-Quigley, C. (Author), Linnemann, A.K (Author), Lopez-Noriega, L. (Author), Magnan, C. (Author), Martinez, M. (Author), Muralidharan, C. (Author), Rodriguez, T.A (Author), Rutter, G.A (Author), Soleimanpour, S.A (Author), Stylianides, T. (Author), Tomas, A. (Author), Wern, F.Y.S (Author), Wretlind, A. (Author), Xu, Y. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
Online Access:View Fulltext in Publisher
LEADER 03564nam a2200697Ia 4500
001 10.2337-db21-0800
008 220706s2022 CNT 000 0 und d
020 |a 1939327X (ISSN) 
245 1 0 |a Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion 
260 0 |b NLM (Medline)  |c 2022 
856 |z View Fulltext in Publisher  |u https://doi.org/10.2337/db21-0800 
520 3 |a Mitochondrial glucose metabolism is essential for stimulated insulin release from pancreatic β-cells. Whether mitofusin gene expression, and hence, mitochondrial network integrity, is important for glucose or incretin signaling has not previously been explored. Here, we generated mice with β-cell-selective, adult-restricted deletion knock-out (dKO) of the mitofusin genes Mfn1 and Mfn2 (βMfn1/2 dKO). βMfn1/2-dKO mice displayed elevated fed and fasted glycemia and a more than fivefold decrease in plasma insulin. Mitochondrial length, glucose-induced polarization, ATP synthesis, and cytosolic and mitochondrial Ca2+ increases were all reduced in dKO islets. In contrast, oral glucose tolerance was more modestly affected in βMfn1/2-dKO mice, and glucagon-like peptide 1 or glucose-dependent insulinotropic peptide receptor agonists largely corrected defective glucose-stimulated insulin secretion through enhanced EPAC-dependent signaling. Correspondingly, cAMP increases in the cytosol, as measured with an Epac-camps-based sensor, were exaggerated in dKO mice. Mitochondrial fusion and fission cycles are thus essential in the β-cell to maintain normal glucose, but not incretin, sensing. These findings broaden our understanding of the roles of mitofusins in β-cells, the potential contributions of altered mitochondrial dynamics to diabetes development, and the impact of incretins on this process. © 2022 by the American Diabetes Association. 
650 0 4 |a animal 
650 0 4 |a Animals 
650 0 4 |a genetics 
650 0 4 |a glucose 
650 0 4 |a Glucose 
650 0 4 |a GTP Phosphohydrolases 
650 0 4 |a guanine nucleotide exchange factor 
650 0 4 |a Guanine Nucleotide Exchange Factors 
650 0 4 |a guanosine triphosphatase 
650 0 4 |a incretin 
650 0 4 |a Incretins 
650 0 4 |a insulin 
650 0 4 |a Insulin 
650 0 4 |a insulin release 
650 0 4 |a Insulin Secretion 
650 0 4 |a Insulin-Secreting Cells 
650 0 4 |a knockout mouse 
650 0 4 |a metabolism 
650 0 4 |a Mfn1 protein, mouse 
650 0 4 |a Mfn2 protein, mouse 
650 0 4 |a Mice 
650 0 4 |a Mice, Knockout 
650 0 4 |a mouse 
650 0 4 |a pancreas islet beta cell 
700 1 |a Akalestou, E.  |e author 
700 1 |a Ali, Y.  |e author 
700 1 |a Alsabeeh, N.  |e author 
700 1 |a Chabosseau, P.  |e author 
700 1 |a Cruciani-Guglielmacci, C.  |e author 
700 1 |a Georgiadou, E.  |e author 
700 1 |a Gu, G.  |e author 
700 1 |a Ibberson, M.  |e author 
700 1 |a Jones, B.  |e author 
700 1 |a Leclerc, I.  |e author 
700 1 |a Legido-Quigley, C.  |e author 
700 1 |a Linnemann, A.K.  |e author 
700 1 |a Lopez-Noriega, L.  |e author 
700 1 |a Magnan, C.  |e author 
700 1 |a Martinez, M.  |e author 
700 1 |a Muralidharan, C.  |e author 
700 1 |a Rodriguez, T.A.  |e author 
700 1 |a Rutter, G.A.  |e author 
700 1 |a Soleimanpour, S.A.  |e author 
700 1 |a Stylianides, T.  |e author 
700 1 |a Tomas, A.  |e author 
700 1 |a Wern, F.Y.S.  |e author 
700 1 |a Wretlind, A.  |e author 
700 1 |a Xu, Y.  |e author 
773 |t Diabetes